LIVE: Burry Is SHORT EVERYTHING!!!! OpenAI's NEW MODELS Are CRAZY... AI Trade Is BACK!?
Speakers
Thread Guy
— Crypto influencer, independent
Summary
Thread Guy discusses the US government's involvement in staggering OpenAI's GPT-5.6 release, framing it as a shift toward state-gated AI access that will enable stock picking based on government-favored companies. He shares several personal long positions and watch setups: AMC is a high-conviction long due to the powerful 2026 movie slate; Eli Lilly benefits from a potential weight-loss drug catalyst; IBB shows a clean biotech breakout; Solana and Pump token are crypto turn-around watchers; Bitcoin and copper are monitored for breakout confirmations. The stream also covers hype around AI regulation, celebrity VC rounds, and the ongoing crypto drawdown.
- OpenAI's GPT-5.6 will be released under government customer-by-customer approval, permanently changing AI model accessibility.
- US administration is expected to favor specific companies with early AI access, making IBM, Dell, Intel, and Micron potential speculative longs.
- AMC is held long despite dilution due to an exceptionally strong 2026 film lineup with major franchise and indie hits.
- Eli Lilly is at all-time highs, driven by AI and biotech momentum plus a pending catalyst in the weight-loss drug Rea.
- IBB biotech ETF displays a textbook breakout, suggesting broad sector strength beyond Eli Lilly.
- Bitcoin and copper are in downtrends; the trader plans to enter long only on reclaim of resistance levels (BTC above 83k, copper above a key level).
- Solana is seen as near a long-term bottom, while Pump.fun token may re-rate if it reclaims its range and executes an airdrop.
- Crypto weakness continues; Gold and silver recover slightly, oil declines, and semis show concerning post-earnings selloffs (Micron -7%).
Ideas
Epic 2026 movie slate lifts AMC
The upcoming 2026 movie lineup is historically strong with major sequels, legacy directors, and indie hits all converging. Despite dilution and poor management at AMC, the sheer box office potential from titles like Spider-Man, Avengers, Toy Story 5, Super Mario Galaxy, Christopher Nolan's Odyssey, and others makes it impossible to be bearish. The speaker refuses to sell AMC because attention and narrative will drive the stock higher.
Government picks AI winners, follow them
The US government is now gatekeeping advanced AI models, deciding which companies get early access. Trump has openly favored specific companies such as IBM, Dell, Intel, and Micron, causing their stocks to rise on his endorsement. With the government in cahoots with AI labs to select corporate winners, speculators can simply follow these signals and buy the named stocks, as they will be given superior intelligence tools and market advantages.
Weight-loss drug catalyst drives Lilly
Eli Lilly is at all-time highs, catching tailwinds from AI and biotech momentum. The key catalyst is the potential FDA approval of the weight-loss drug Rea, which could be a goldmine similar to GLP-1 agonists. Solving obesity would be a holy grail, and Lilly as the manufacturer stands to benefit enormously. The setup is compelling even though the regulatory timeline is uncertain.
IBB biotech breakout looks strong
The IBB biotech ETF just printed a textbook breakout above resistance with a clean 5% move. The chart is 'nuts' and not driven solely by Eli Lilly, which is only ~1% of the index. This suggests broad-based momentum in biotech, making it an attractive breakout buy.
Buy Bitcoin only above 83k
Bitcoin is hammering a support area around $60k but remains in a clear downtrend with lower highs. The speaker is not a hero bottom-sniper and wants confirmation. A breakout above $83k would signal a narrative change and justify a long entry, with a further buy at $98k as momentum returns. Until then, he stays away.
Wait for copper breakout to buy
Copper has been in a brutal sell-off and looks bad near-term. The speaker wants to buy only on a reclaim of resistance from above, preferring to wait for strength and a trend change rather than trying to catch the falling knife. The level is a specific chart level he identifies as his entry trigger.
Solana near bottom, long-term buy
Solana is historically oversold and in a similar position to its 2023 bottom at $8, when almost no one believed it would recover. Current negative sentiment and price levels suggest a long-term buying opportunity. If you buy now with a six-month to one-year horizon, it will likely age well, as the chain still has strong consumer application potential despite the recent downtrend.
Watch Pump for reclaim above 17
Pump.fun token has been crushed (-86%) but the underlying platform still generates significant revenue and user attention. The thesis to turn bullish hinges on reclaiming a key level (around $17), improved growth metrics, and a potential airdrop that restores goodwill. If the token reclaims its prior trading range, it could rip given the undervaluation relative to platform economics.
